Healthcare Industry News: Wound Dressing
News Release - May 17, 2006
Smith & Nephew Announces European Launch of Enhanced Allevyn(TM) Adhesive DressingsHULL, England, May 17 (HSMN NewsFeed) -- Smith & Nephew's (LSE: SN ; NYSE: SNN ) Advanced Wound Management division, announced today that it is launching new and improved versions of Allevyn Adhesive and Allevyn Sacrum that now have up to three times increased fluid handling capacity.
The new Allevyn Adhesive dressings now have a more breathable top film and a faster rate of fluid uptake. This combined with the existing benefits of Allevyn helps to deliver the optimal moist wound environment for the promotion of faster healing.
"2006 represents a very important year for Allevyn Wound Dressings and these improvements will help strengthen our position further as the leading global brand within the foam dressings market," said Joe Woody, President, Smith & Nephew Advanced Wound Management. The enhanced products offer even more benefits to our customers and will continue to improve the quality of life of their patients. "
Allevyn helps to facilitate healing by reducing the risk of maceration and maintaining an optimal moist wound environment. Allevyn offers the clinician a clinically proven range of dressings that are cost effective both for the clinician and the buyer.
John Timmons, Lecturer in Post Registration Nursing, Glasgow Caledonian University said "I have been using the new Allevyn(TM) Adhesive products on my patients the majority of whom are in nursing homes. My patients have commented that these dressings are really comfortable and I have found that they stay in place without causing any reaction or maceration to the surrounding skin. Usage of the product has given me confidence in the dressing wear-time and its ability to effectively manage exudate whilst always maintaining a moist wound environment. This makes my patients lives better and my job easier."
Smith & Nephew Advanced Wound Management, with headquarters in Hull, UK employs more than 2,500 people around the world with approximately half based in their main manufacturing facility in Hull. The organisation also has manufacturing centres in the US in Largo, Florida
(TM) Trademark of Smith & Nephew
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The company has more than 8,500 employees and operates in 33 countries around the world and generated sales of nearly $2.6 billion.
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.
Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Source: Smith & Nephew
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsSmith & Nephew acquires novel cementless partial knee system
Smith & Nephew Launches 'Turn-Key' Robotic-Assisted Surgical System; Designed to Quickly Augment the Orthopaedic Team's Skills Set for Greater Accuracy(1-3)¥, Improved Outcomes(4), and Potentially an Immediate Scalable Solution to NHS
Smith & Nephew to expand Real Intelligence digital ecosystem and CORI(TM) Surgical System with total hip arthroplasty